Fibrotic valvular heart disease is not related to chemical class but to biological function:: 5-HT2B receptor activation plays crucial role

被引：25

作者：

Horowski, R ^{[1
]}

Jähnichen, S

机构：

[1] NeuroBiotec GmbH, Berlin, Germany

[2] Free Univ Berlin, Inst Pharm, D-1000 Berlin, Germany

来源：

MOVEMENT DISORDERS | 2004年 / 19卷 / 12期

关键词：

D O I：

10.1002/mds.20329

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：1523 / 1524

页数：2

共 16 条

[1] Characterization of phospholipase C activity at h5-HT2C compared with h5-HT2B receptors:: influence of novel ligands upon membrane-bound levels of [3H]phosphatidylinositols [J].

Cussac, D ;

Newman-Tancredi, A ;

Quentric, Y ;

Carpentier, N ;

Poissonnet, G ;

Parmentier, JG ;

Goldstein, S ;

Millan, MJ .

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 (03) :242-252

[2]

Fitzgerald LW, 2000, MOL PHARMACOL, V57, P75

[3] Further evidence that 5-HT-induced relaxation of pig pulmonary artery is mediated by endothelial 5-HT2B receptors [J].

Glusa, E ;

Pertz, HH .

BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (03) :692-698

[4] Severe multivalvular heart disease: A new complication of the ergot derivative dopamine agonists [J].

Horvath, J ;

Fross, RD ;

Kleiner-Fisman, G ;

Lerch, R ;

Stalder, H ;

Liaudat, S ;

Raskoff, WJ ;

Flachsbart, KD ;

Rakowski, H ;

Pache, JC ;

Burkhard, PR ;

Lang, AE .

MOVEMENT DISORDERS, 2004, 19 (06) :656-662

[5] Pharmacological characterisation of human 5-HT2 receptor subtypes [J].

Jerman, JC ;

Brough, SJ ;

Gager, T ;

Wood, M ;

Coldwell, MC ;

Smart, D ;

Middlemiss, DN .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 414 (01) :23-30

[6] Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertension [J].

Launay, JM ;

Hervé, P ;

Peoc'h, K ;

Tournois, C ;

Callebert, J ;

Nebigil, CG ;

Etienne, N ;

Drouet, L ;

Humbert, M ;

Simonneau, G ;

Maroteaux, L .

NATURE MEDICINE, 2002, 8 (10) :1129-1135

[7] Overexpression of the serotonin 5-HT2B receptor in heart leads to abnormal mitochondrial function and cardiac hypertrophy [J].

Nebigil, CG ;

Jaffré, F ;

Messaddeq, N ;

Hickel, P ;

Monassier, L ;

Launay, JM ;

Maroteaux, L .

CIRCULATION, 2003, 107 (25) :3223-3229

[8] Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor.: III.: Agonist and antagonist properties at serotonin, 5-HT1 and 5-HT2, receptor subtypes [J].

Newman-Tancredi, A ;

Cussac, D ;

Quentric, Y ;

Touzard, M ;

Verrièle, L ;

Carpentier, N ;

Millan, MJ .

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 303 (02) :815-822

[9]

Pertz H. E. I. N. Z., 1999, Ergot: The genus Claviceps, P411

[10]

PODVALOVA I, 1972, RES CLIN STUD HEADAC, V3, P325

← 1 2 →